These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 10754991

  • 1. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
    Ruymann FB, Grovas AC.
    Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
    [Abstract] [Full Text] [Related]

  • 2. Soft tissue sarcoma in children: prognosis and management.
    Koscielniak E, Morgan M, Treuner J.
    Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
    [Abstract] [Full Text] [Related]

  • 3. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, Wiener ES, Maurer HM, Crist WM.
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W, Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Pediatr Blood Cancer; 2004 Jan; 42(1):64-73. PubMed ID: 14752797
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.
    Ruymann FB, Vietti T, Gehan E, Wiener E, Wharam M, Newton WA, Maurer H.
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):331-7. PubMed ID: 7583389
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group.
    Bochennek K, Dantonello T, Koscielniak E, Claviez A, Dirksen U, Sauerbrey A, Beilken A, Klingebiel T.
    Klin Padiatr; 2013 Nov; 225(6):309-14. PubMed ID: 23946091
    [Abstract] [Full Text] [Related]

  • 17. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E, Jürgens H, Winkler K, Bürger D, Herbst M, Keim M, Bernhard G, Treuner J.
    Cancer; 1992 Nov 15; 70(10):2557-67. PubMed ID: 1482503
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.